Ever Glory United Holdings First Half 2025 Earnings: EPS: S$0.013 (vs S$0.017 in 1H 2024)
Ever Glory United Holdings (Catalist:ZKX) First Half 2025 Results
Key Financial Results
Revenue: S$28.6m (down 11% from 1H 2024).
Net income: S$4.66m (down 19% from 1H 2024).
Profit margin: 16% (down from 18% in 1H 2024). The decrease in margin was driven by lower revenue.
EPS: S$0.013 (down from S$0.017 in 1H 2024).
Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ever Glory United Holdings shares are up 8.9% from a week ago.
Risk Analysis
It is worth noting though that we have found 1 warning sign for Ever Glory United Holdings that you need to take into consideration.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
MVV Energie Third Quarter 2025 Earnings: EPS: €0.36 (vs €0.38 in 3Q 2024)
Explore MVV Energie's Fair Values from the Community and select yours MVV Energie (ETR:MVV1) Third Quarter 2025 Results Key Financial Results Revenue: €1.35b (up 3.4% from 3Q 2024). Net income: €23.7m (down 4.4% from 3Q 2024). Profit margin: 1.7% (down from 1.9% in 3Q 2024). The decrease in margin was driven by higher expenses. EPS: €0.36 (down from €0.38 in 3Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period MVV Energie's share price is broadly unchanged from a week ago. Risk Analysis Before we wrap up, we've discovered 2 warning signs for MVV Energie (1 is significant!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
PolyPeptide Group First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags
Explore PolyPeptide Group's Fair Values from the Community and select yours PolyPeptide Group (VTX:PPGN) First Half 2025 Results Key Financial Results Revenue: €167.1m (up 24% from 1H 2024). Net loss: €26.5m (loss widened by 133% from 1H 2024). €0.80 loss per share (further deteriorated from €0.35 loss in 1H 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period PolyPeptide Group Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) missed analyst estimates by 40%. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Life Sciences industry in Switzerland. Performance of the Swiss Life Sciences industry. The company's shares are up 25% from a week ago. Risk Analysis Before we wrap up, we've discovered 1 warning sign for PolyPeptide Group that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
8 minutes ago
- Yahoo
Earnings Miss: PVA TePla AG Missed EPS By 33% And Analysts Are Revising Their Forecasts
Explore PVA TePla's Fair Values from the Community and select yours It's shaping up to be a tough period for PVA TePla AG (ETR:TPE), which a week ago released some disappointing second-quarter results that could have a notable impact on how the market views the stock. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at €61m, statutory earnings missed forecasts by an incredible 33%, coming in at just €0.13 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. After the latest results, the eleven analysts covering PVA TePla are now predicting revenues of €260.3m in 2025. If met, this would reflect a reasonable 2.3% improvement in revenue compared to the last 12 months. Statutory earnings per share are forecast to nosedive 21% to €0.81 in the same period. Before this earnings report, the analysts had been forecasting revenues of €262.9m and earnings per share (EPS) of €0.83 in 2025. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year. Check out our latest analysis for PVA TePla Althoughthe analysts have revised their earnings forecasts for next year, they've also lifted the consensus price target 5.8% to €23.01, suggesting the revised estimates are not indicative of a weaker long-term future for the business. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values PVA TePla at €29.00 per share, while the most bearish prices it at €15.50. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await PVA TePla shareholders. Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that PVA TePla's revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 4.7% growth on an annualised basis. This is compared to a historical growth rate of 17% over the past five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 8.8% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than PVA TePla. The Bottom Line The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that PVA TePla's revenue is expected to perform worse than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple PVA TePla analysts - going out to 2027, and you can see them free on our platform here. It might also be worth considering whether PVA TePla's debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
